John Fitzpatrick

speaker
244 appearances 1 recordings 1 series first heard Jan 2026 last heard 13 Jan

John Fitzpatrick’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Jan OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Jan 2026 with 1.

Appearances

newest first · ▶ plays the moment
We'll tailor them to our own use cases.
And then we operate those in dedicated private instances.
So we have different models for different use cases and they operate all within a Nitro environment.
So none of your data leaves our environment.
We also never store any customer data or documents.
And I think that's really, really important, particularly for enterprise businesses that are very sensitive to the adoption of AI.
So this means we don't have your data, we process it and then it's gone.
So we can never use it to train a model and it can never be exposed.
And so under the hood, it's a selection of various AI models that we've carefully selected and tailored to our use cases.
Yeah, so they can.
They can start within our PDF products and they can start with a blank document and just work on it.
The workflows tend to be that the document was generated elsewhere and they're making...
edits to it, they're combining documents, they're doing redaction and those types of operations on PDFs that have already been created.
And then for things like signing, they will have created the contract or whatever else it may be, and then they will put it into our signed product to be able to send it out for signature.
Let's hear it.
um i guess so for me one of the most jaw-dropping moments was it came from a customer in the pharma space right so um they have to process these huge quantities of patient intake forms um in the clinical space and so um again this is really boring to many people but excites me and and i think you know in a lot of cases the boring application of ai is actually the best use cases for it so
So these are documents that the pharma business would have to send out.
The end patients then would fill them in either manually on a tablet or on their laptop.
The company would then get all of those forms back.
Often they'd be generated from Word documents, these flat documents, and they then have to manually go through them.
Showing 81–100 of 244 · page 5 of 13 ← Previous Next →